Score Breakdown
Below average.
Under Armour is a deteriorating brand attempting a turnaround in the most competitive segment of consumer discretionary. While management is making the right strategic moves (SKU rationalization, full-price focus, reduced promotions), the execution window is narrow and the competitive moat is thin. Revenue has declined for multiple years, North America is structurally weak, footwear is losing share to On/Hoka/New Balance, and the balance sheet carries hidden liabilities ($265M supply chain financing, $90M insurance clawback, full U.S. DTA writeoff). The 7.25% borrowing rate and negative interest coverage signal credit stress. Kevin Plank's dual-class voting control removes accountability. At ~0.55x P/S, the stock appears cheap, but the business may deserve a distressed multiple given negative FCF margins, governance issues, and no clear path to sustainable mid-single-digit FCF margins. The Q3 FY2026 earnings beat was driven by working capital timing and a massive tax benefit, not fundamental improvement. This is a 'prove it' story where the burden of proof is on management, and the risk/reward does not compensate for the uncertainty.
Paying for a dream.
Major red flags in SEC filings.
Buying back shares.
No data.
Plenty of cash.
Some skeptics.
Below average.
🐻 Why Bears Hate It
The short thesis centers on a persistent revenue decline, particularly in North America where sales fell 8% in the most recent quarter. Bears argue the turnaround is 'never-ending' and point to a 12% drop in footwear revenue as a sign that UA is losing the innovation race to specialty brands. Additionally, Citi recently downgraded the stock to 'Sell' (Feb 2026), citing weak DTC traffic and intense competition (Front Office Sports, Feb 2025; Intellectia AI, Feb 2026).
🔍 What's In The SEC Filings
Under Armour faces a critical liquidity and legal crisis driven by a $90 million insurance clawback and a management admission that U.S. profitability is no longer probable.
Forced repayment of $90 million in insurance proceeds following a legal reversal.
“the Company is required to repay the $90 million of insurance proceeds previously funded by the insurance carriers for the settlement amount and defense costs from the Consolidated Securities Action.”
A Fourth Circuit decision reversed a lower court ruling, creating an immediate and massive cash liability for a settlement the company thought was covered.
Total write-down of U.S. deferred tax assets signaling no expected profitability.
“the Company has recorded valuation allowances on all U.S. federal deferred tax assets as of December 31, 2025.”
Under GAAP, this is a 'white flag' indicating management no longer believes it is more likely than not that they will be profitable enough in the U.S. to use their tax credits.
Aggressive expansion of a supply chain finance program to manage cash.
“The Company’s outstanding payment obligations under this program were $265.3 million as of December 31, 2025 (March 31, 2025: $143.8 million).”
This 'reverse factoring' effectively hides bank debt within Accounts Payable, artificially boosting operating cash flow metrics while increasing reliance on third-party liquidity.
Usage of bill-and-hold arrangements to pull forward revenue.
“the Company entered into a contract in EMEA that met the criteria of bill and hold arrangement under ASC Topic 606 and recognized approximately $4.0 million of revenue.”
Recognizing revenue for products not yet shipped is a classic aggressive accounting tactic to meet quarterly targets during periods of declining organic demand.
Investors should apply a significant 'governance discount' and treat the $265 million supply chain finance as debt; the loss of U.S. tax assets suggests a long-term impairment of the domestic core business valuation.
Founder Kevin Plank maintains 10:1 voting control via Class B shares, insulating management from accountability despite a 7.25% interest rate on new debt and the failure of the 'Curry Brand' leading to significant restructuring costs.